Atlantic International Corp.
HealthcareNASDAQ:ATLN · NASDAQ Global Market
-$0.10 today
Vol 0.36M · Avg 0.44M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
185.2%
avg 264.3%
ROIC
-801.2%
avg -86.3%
ROA
-52.5%
avg -150.2%
Analysis
ROE is currently the strongest return metric at 185.2% versus its period average of 264.3%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jeffrey Jagid | Chief Executive Officer & Director | $1.40M | — | 56 | $1.00M | 1.26% |
Michael Tenore | General Counsel & Secretary | $413,533.00 | — | 50 | $1.84M | 2.32% |
James Radvany | Chief Financial Officer of Lyneer Staffing Solutions LLC | — | — | 66 | $0.00 | <0.01% |
Kevin J. Murphy | Chief Financial Officer | — | — | 49 | $0.00 | <0.01% |
Todd McNulty | Chief Executive Officer of Lyneer Staffing Solutions LLC | — | — | 58 | — | — |
Guus Franke | Executive Chairman of the Board | — | — | 50 | $12.52M | 15.77% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -37.3% | +96.7% (7yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -37.3% over three years. Forward estimates point to Revenue at +96.7% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Prenetics Global Limited
NASDAQ:PRE
$367.72M
Anteris Technologies Global Corp.
NASDAQ:AVR
$336.61M
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
$150.58M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Cassava Sciences, Inc.
SAVA
$63.77M
China SXT Pharmaceuticals, Inc.
SXTC
$1.99M
Who manages ATLN?
Atlantic International Corp. (ATLN) lists 6 active executives. The top listed executive is James Radvany, Chief Financial Officer of Lyneer Staffing Solutions LLC.
Are ATLN insiders buying or selling?
Recent insider activity shows net buying of $31.96M.
Explore More
Continue the stock analysis
Jump to another research area for this company.